drugset / Trial / NCT00630929

Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)

NCT00630929

Phase 4 Completed 388 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the efficacy and safety of celecoxib versus ibuprofen in subjects with osteoarthritis (OA) of the knee.

Timeline

Start
2003-01
Primary completion
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Comparator Ibuprofen Small molecule 800 mg Oral

Indications